Pay in 4 interest-free payments of $6.16 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
GLP-1 medications like semaglutide and tirzepatide are possible treatment options that healthcare providers may consider for weight management during menopause
The Phase 2 trial reference point The Phase 2 retatrutide trial (Jastreboff et al., New England Journal of Medicine 2023) enrolled 338 adults across placebo and retatrutide arms at 1, 4, 8, and 12 mg weekly
Poidvin A, Touz E, Ecosse E, Landier F, Bjot Y, Giroud M, et al
Store unreconstituted lyophilised peptide vials at 20C, but once reconstituted, refrigeration at 28C is the correct protocol
Related Medications Wegovy (semaglutide) Rybelsus (semaglutide) Mounjaro (tirzepatide) Zepbound (tirzepatide) Saxenda (liraglutide) Victoza (liraglutide) Trulicity (dulaglutide) Sources Medications Containing Semaglutide Marketed for Type 2 Diabetes or Weight Loss
In: Elsner P., Maibach H., eds
US$ 22.80
US$ 29.91
US$ 20.79
US$ 22.45
